Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Fatty liver disease increases risk for impaired myocardial perfusion

02.12.20151876
Patients undergoing primary PCI for STEMI who present with moderate or severe fatty liver disease were more likely to have impairment of myocardial perfusion compared with patients with less severe disease, according to recent findings.

FDA approves rosuvastatin for use in youth aged 8 to 17 with HeFH

01.12.20151874
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged 8 to 17 years with heterozygous familial hypercholesterolemia.

Rivaroxaban associated with more GI bleeding than warfarin; fatal GI bleeds rare

30.11.20151841
Compared with warfarin, rivaroxaban was associated with increased gastrointestinal bleeding, according to new data from the ROCKET AF trial.

Premenstrual syndrome may confer elevated risk for hypertension

25.11.20151969
Women with moderate-to-severe premenstrual syndrome had a 40% increased risk for hypertension later in life compared with women with few or no menstrual symptoms in a recent study.

CardioBrief: At-Home Statin Intolerance Test Faces Skeptics Experts question role for the genetic test, now promoted direct to consumers

24.11.20150
A small laboratory company, Boston Heart Diagnostics, has introduced and is promoting direct to consumers "the first and only at-home saliva laboratory developed test," which it says will help identify people who are likely to experience side effects from taking a statin.

Heart Surgery Risks Lower With Preop Beta-Blocker Plus Statin?

23.11.20152252
The combination of statins and beta-blockers before cardiac surgery was associated with lower risk of certain complications afterward, an observational study showed.

WHO/Europe International Conference on Cardiovascular Diseases was held in St.Petersburg

20.11.20152162
In St.petersburg WHO/Europe International Conference on Cardiovascular Diseases was held. Leading experts discussed prevention and control of cardiovascular diseases according to the World and European programmes.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.